Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
DTAS Strategic Advisory Consulting ( Life Sciences Supply Chain & Operations ) IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA offers a broad
Role At Visium, youll have the opportunity to take on an entrepreneurial role, contributing to the organization’s growth and finding innovative ways to create meaningful impact for clients. Your mission will involve advising C-Level executives on
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Basic information Business line Technology & Transformation City Basel, Geneva, Zurich Experience level Experienced Working time percentage 80% - 100% Date published 08-Oct-2025 Req # 21723 Job description Location: Basel, Zurich, Geneva Work Pattern Percentage: 80-100%
Visium combines strategy, frontier AI, and deep regulated-industry expertise to build and deploy AI-native systems that reinvent how businesses operate - unlocking the value of AI at scale. Were not a strategy firm that ships slide
IT Security Engineer sciCORE is the center of competence for scientific computing at the University of Basel, the oldest university in Switzerland and consistently ranked among the best universities in the world. The University is highly
Salary RangeCHF150,500.00 - CHF279,500.00Job Description SummaryWe’re a team of dedicated and smart people united by a drive to achieve together. You will ensure Novartis Social Impact & Sustainability (SI&S) Strategy will remain fit for purpose and
Revolution Medicines is a late‑stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Principal, Health Economics, Health Technology Assessment IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA offers a broad range of solutions that harness
At Machine Learning Architects Basel (MLAB), we assist and empower people and organizations in designing, building, and operating reliable data and machine learning solutions. In doing so, our data and AI journeys and effective solution patterns enable our
Director in Quality & Regulatory Management - Advisory Services Grow here. Go further. Zürich by agreement 100% Advisory Everyone welcome ID: WD Your Impact Sell, lead and, together with the team, deliver high-impact projects engaging with
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and